Allison Hilberer
Program Leader- BCOP, Photosafety, & 96-Well Cytotoxicity at Institute for In Vitro Sciences, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Douglas A. Donahue, MS, DABT, ERT
I started working with Allison in 2011 when Kao Corporation (Japan) decided to investigate the use of a new ocular irritation assay. IIVS assigned Allison to this new ocular irritation procedure. Allison was in charge of reviewing published information on the assay, in-house protocol development, validation, and implementation of the assay at IIVS. During all of the time working with Allison, she was an utmost professional with not only myself but with my old colleagues in Japan. She has shown to be a great asset to IIVS as a study director and I would highly recommend Allison as a study director.
Douglas A. Donahue, MS, DABT, ERT
I started working with Allison in 2011 when Kao Corporation (Japan) decided to investigate the use of a new ocular irritation assay. IIVS assigned Allison to this new ocular irritation procedure. Allison was in charge of reviewing published information on the assay, in-house protocol development, validation, and implementation of the assay at IIVS. During all of the time working with Allison, she was an utmost professional with not only myself but with my old colleagues in Japan. She has shown to be a great asset to IIVS as a study director and I would highly recommend Allison as a study director.
Douglas A. Donahue, MS, DABT, ERT
I started working with Allison in 2011 when Kao Corporation (Japan) decided to investigate the use of a new ocular irritation assay. IIVS assigned Allison to this new ocular irritation procedure. Allison was in charge of reviewing published information on the assay, in-house protocol development, validation, and implementation of the assay at IIVS. During all of the time working with Allison, she was an utmost professional with not only myself but with my old colleagues in Japan. She has shown to be a great asset to IIVS as a study director and I would highly recommend Allison as a study director.
Douglas A. Donahue, MS, DABT, ERT
I started working with Allison in 2011 when Kao Corporation (Japan) decided to investigate the use of a new ocular irritation assay. IIVS assigned Allison to this new ocular irritation procedure. Allison was in charge of reviewing published information on the assay, in-house protocol development, validation, and implementation of the assay at IIVS. During all of the time working with Allison, she was an utmost professional with not only myself but with my old colleagues in Japan. She has shown to be a great asset to IIVS as a study director and I would highly recommend Allison as a study director.
Credentials
-
DABT
American Board of Toxicology, Inc.Jan, 2022- Nov, 2024 -
Diplomate of the American Board of Toxicology (DABT)
American Board of Toxicology, Inc.Jan, 2016- Nov, 2024
Experience
-
Institute for In Vitro Sciences, Inc.
-
United States
-
Research Services
-
1 - 100 Employee
-
Program Leader- BCOP, Photosafety, & 96-Well Cytotoxicity
-
Mar 2019 - Present
-
-
Toxicologist/ Study Director
-
Jul 2011 - Present
-
-
Laboratory Supervisor
-
Nov 2009 - Dec 2014
-
-
Senior Biologist
-
Jul 2008 - Nov 2009
-
-
Biologist I-III
-
Nov 2004 - Jul 2008
-
-
Education
-
2019 - 2021
University of Florida
Graduate Certificate in Clinical Toxicology, Clinical Toxicology -
2007 - 2011
George Mason University
Master of Science, Biology -
1999 - 2001
Keuka College
Bachelor of Arts, Biology 7-12 -
1998 - 1999
Finger Lakes Community College
Associate in Arts & Sciences, Biology
Community
